Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Ciprofloxacin · 3 trials · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Ciprofloxacin Extended-Release Tablets 500 mg |
| 2 | ACTIVE_COMPARATOR | Cipro® XR Tablets 500 mg |
| Name | Type | Description |
|---|---|---|
| Ciprofloxacin Extended-Release Tablets 500 mg | DRUG | 500mg, single dose fasting |
| Cipro® XR Tablets (500 mg | DRUG | 500mg, single dose fasting |
| Ciprofloxacin Extended-Release Tablets 1000 mg | DRUG | 1000mg, single dose fasting |
| Cipro® XR Tablets 1000 mg | DRUG | 1000mg, single dose fasting |
Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and/or non-pregnant, non-lactating female. 1. Women of childbearing potential must have negative serum beta human chorionic gonadotropin (β-HCG) pregnancy tests performed within 14 days prior to the start of the study and on the eveni...